Inotiv Inc (NASDAQ:NOTV)

7.45
Delayed Data
As of Jan 27
 +0.65 / +9.56%
Today’s Change
3.65
Today|||52-Week Range
42.63
+50.81%
Year-to-Date
SECTOR
Commercial Services
INDUSTRY
Miscellaneous Commercial Services
MARKET CAP
$169.3M

Company Description

Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Research Services and Research Products. The Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

Contact Information

Inotiv, Inc.
2701 Kent Avenue
West Lafayette Indiana 47906-1382
P:(765) 463-4527
Investor Relations:

Employees

Shareholders

Other institutional27.97%
Individual stakeholders20.93%
Mutual fund holders18.89%

Top Executives

Robert LeasurePresident, Chief Executive Officer & Director
John Gregory BeattieCOO-Discovery & Development Services
Beth A. TaylorChief Financial Officer & Senior Vice President
Mo DastagirChief Technology Officer
Adrian HardyExecutive Vice President